Final answer:
For the RA patient on etanercept, the low hemoglobin level of 9 should be reported to the healthcare provider, as it could indicate anemia related to the disease or medication side effects. - hgb 9
Step-by-step explanation:
The laboratory finding that should be reported to the healthcare provider for a patient with rheumatoid arthritis (RA) who is prescribed etanercept and is experiencing joint swelling, symmetric joint pain, and deformities of both hands is the hemoglobin (Hgb) level of 9.
This low hemoglobin level could indicate anemia, which is common in individuals with RA and can be a sign of worsening disease or a side effect of medications. It is crucial to address this finding because it can have significant implications for the patient's overall health and treatment plan.